The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome
Open accessAbstract
Reports of Guillain-Barré syndrome (GBS) have emerged during the Coronavirus disease 2019 (COVID-19) pandemic. This epidemiological and cohort study sought to investigate any causative association between COVID-19 infection and GBS. The epidemiology of GBS cases reported to the UK National Immunoglobulin Database was studied from 2016 to 2019 and compared to cases reported during the COVID-19 pandemic. Data were stratified by hospital trust and region, with numbers of reported cases per month. UK population data for COVID-19 infection were collated from UK public health bodies. In parallel, but separately, members of the British Peripheral Nerve Society prospectively reported incident cases of GBS during the pandemic at their hospitals to a central register. The clinical features, investigation findings and outcomes of COVID-19 (definite or probable) and non-COVID-19 associated GBS cases in this cohort were compared. The incidence of GBS treated in UK hospitals from 2016 to 2019 was 1.65–1.88 per 100 000 individuals per year. GBS incidence fell between March and May 2020 compared to the same months of 2016–19. GBS and COVID-19 incidences during the pandemic also varied between regions and did not correlate with one another (r = 0.06, 95% confidence interval: −0.56 to 0.63, P = 0.86). In the independent cohort study, 47 GBS cases were reported (COVID-19 status: 13 definite, 12 probable, 22 non-COVID-19). There were no significant differences in the pattern of weakness, time to nadir, neurophysiology, CSF findings or outcome between these groups. Intubation was more frequent in the COVID-19 affected cohort (7/13, 54% versus 5/22, 23% in COVID-19-negative) attributed to COVID-19 pulmonary involvement. Although it is not possible to entirely rule out the possibility of a link, this study finds no epidemiological or phenotypic clues of SARS-CoV-2 being causative of GBS. GBS incidence has fallen during the pandemic, which may be the influence of lockdown measures reducing transmission of GBS inducing pathogens such as Campylobacter jejuni and respiratory viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
Li, Y., Bai, W., & Hashikawa, T. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25728 · Cited by 2,266
Cao-Lormeau, V.-M., Blake, A., Mons, S., Lastère, S., Roche, C., Vanhomwegen, J., Dub, T., Baudouin, L., Teissier, A., Larre, P., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00562-6 · Cited by 2,205
Self-citationNeurological associations of COVID-19
Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., Kneen, R., Defres, S., Sejvar, J., & Solomon, T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30221-0 · Cited by 2,156
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
Yuki, N., & Hartung, H.-P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1114525 · Cited by 1,260
Guillain–Barré Syndrome Associated with SARS-CoV-2
Toscano, G., Palmerini, F., Ravaglia, S., Ruiz, L., Invernizzi, P., Cuzzoni, M. G., Franciotta, D., Baldanti, F., Daturi, R., Postorino, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009191 · Cited by 1,260
Varatharaj, A., Thomas, N., Ellul, M. A., Davies, N. W. S., Pollak, T. A., Tenorio, E. L., Sultan, M., Easton, A., Breen, G., Zandi, M., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30287-x · Cited by 1,246
Self-citationThe emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
Paterson, R. W., Brown, R. L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., Jayaseelan, D. L., Kumar, G., Raftopoulos, R. E., Zambreanu, L., et al. (2020) · Brain · doi:10.1093/brain/awaa240 · Cited by 1,124
Self-citationGuillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
Zhao, H., Shen, D., Zhou, H., Liu, J., & Chen, S. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30109-5 · Cited by 993
Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis
Sejvar, J. J., Baughman, A. L., Wise, M., & Morgan, O. W. (2011) · Neuroepidemiology · doi:10.1159/000324710 · Cited by 960
Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria
Fokke, C., van den Berg, B., Drenthen, J., Walgaard, C., van Doorn, P. A., & Jacobs, B. C. (2014) · Brain · doi:10.1093/brain/awt285 · Cited by 792
Peripheral neuropathies and anti-glycolipid antibodies
Willison, H. J. (2002) · Brain · doi:10.1093/brain/awf272 · Cited by 710
Self-citationSejvar, J. J., Kohl, K. S., Gidudu, J., Amato, A., Bakshi, N., Baxter, R., Burwen, D. R., Cornblath, D. R., Cleerbout, J., Edwards, K. M., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.06.003 · Cited by 652
Accessory proteins of SARS-CoV and other coronaviruses
Liu, D. X., Fung, T. S., Chong, K. K.-L., Shukla, A., & Hilgenfeld, R. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.06.013 · Cited by 431
COVID-19 and stroke—A global World Stroke Organization perspective
Markus, H. S., & Brainin, M. (2020) · International Journal of Stroke · doi:10.1177/1747493020923472 · Cited by 392
Angoulvant, F., Ouldali, N., Yang, D. D., Filser, M., Gajdos, V., Rybak, A., Guedj, R., Soussan-Banini, V., Basmaci, R., Lefevre-Utile, A., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa710 · Cited by 306
Association or causation: evaluating links between "environment and disease".
Lucas, R. M., & McMichael, A. J. (2005) · Europe PMC (PubMed Central) · Cited by 211
Guillain-Barré syndrome after exposure to influenza virus
Lehmann, H. C., Hartung, H.-P., Kieseier, B. C., & Hughes, R. A. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70140-7 · Cited by 199
Nodal proteins are target antigens in Guillain‐Barré syndrome
Devaux, J. J., Odaka, M., & Yuki, N. (2012) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2012.00372.x · Cited by 193
Tam, C. C., O'Brien, S. J., Petersen, I., Islam, A., Hayward, A., & Rodrigues, L. C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000344 · Cited by 193
Kaida, K., Ariga, T., & Yu, R. K. (2009) · Glycobiology · doi:10.1093/glycob/cwp027 · Cited by 155
Uncini, A., Vallat, J., & Jacobs, B. C. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324491 · Cited by 139
Neurological involvement of coronavirus disease 2019: a systematic review
Ghannam, M., Alshaer, Q., Al-Chalabi, M., Zakarna, L., Robertson, J., & Manousakis, G. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09990-2 · Cited by 119
Statistical methods in cancer research: Volume 2. The design and analysis of cohort studies
Fox, A. J. (1989) · Journal of Epidemiology & Community Health · doi:10.1136/jech.43.1.92-a · Cited by 114
Mary, B., Maurya, S., Arumugam, S., Kumar, V. S., & Jayandharan, G. R. (2019) · FEBS Journal · doi:10.1111/febs.15013 · Cited by 105
The Curious Case of the Missing Strokes During the COVID-19 Pandemic
de Sousa, D. A., Sandset, E. C., & Elkind, M. S. V. (2020) · Stroke · doi:10.1161/strokeaha.120.030792 · Cited by 93
Antibodies to Heteromeric Glycolipid Complexes in Guillain-Barré Syndrome
Rinaldi, S., Brennan, K. M., Kalna, G., Walgaard, C., van Doorn, P. A., Jacobs, B. C., Yu, R. K., Månsson, J., Goodyear, C. S., & Willison, H. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082337 · Cited by 77
Self-citationDeclining Guillain-Barré Syndrome after Campylobacteriosis Control, New Zealand, 1988–2010
Baker, M. G., Kvalsvig, A., Zhang, J., Lake, R., Sears, A., & Wilson, N. (2012) · Emerging infectious diseases · doi:10.3201/eid1802.111126 · Cited by 57
Shala, A., Regazzoni, L., Daci, A., Orioli, M., Brezovska, K., Panovska, A. P., Beretta, G., & Šuturkova, L. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.11.005 · Cited by 46
Cited by
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00084-5 · Cited by 2,189
“Whether COVID-19 is associated with Guillain-Barré syndrome remains unclear; 26 our data were also equivocal, with HRs increased with COVID-19 compared with other respiratory tract infections but not with influenza (table 3), and increased compared with three of the four other index health events…”
Steinmetz, J. D., Seeher, K. M., Schiess, N., Nichols, E., Cao, B., Servili, C., Cavallera, V., Cousin, E., Hagins, H., Moberg, M. E., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00038-3 · Cited by 2,019
Self-citationLi, X., Raventós, B., Roel, E., Pistillo, A., Martinez-Hernandez, E., Delmestri, A., Reyes, C., Strauss, V., Prieto-Alhambra, D., Burn, E., et al. (2022) · BMJ · doi:10.1136/bmj-2021-068373 · Cited by 118
Immune-Mediated Mechanisms of COVID-19 Neuropathology
Dunai, C., Collie, C., & Michael, B. D. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.882905 · Cited by 22
Atzenhoffer, M., Auffret, M., Pegat, A., Masmoudi, K., Khouri, C., Bertin, B., & Vial, T. (2022) · Clinical Drug Investigation · doi:10.1007/s40261-022-01164-4 · Cited by 20
Metadata
- Authors
- Keddie, S., Pakpoor, J., Mousele, C., Pipis, M., Machado, P. M., Foster, M., Record, C. J., Keh, R. Y. S., Fehmi, J., Paterson, R. W., Bharambe, V., Clayton, L. M., Allen, C., Price, O., Wall, J., Kiss-Csenki, A., Rathnasabapathi, D. P., Geraldes, R., Yermakova, T., King-Robson, J., Zosmer, M., Rajakulendran, S., Sumaria, S., Farmer, S. F., Nortley, R., Marshall, C. R., Newman, E. J., Nirmalananthan, N., Kumar, G., Pinto, A. A., Holt, J., Lavin, T. M., Brennan, K. M., Zandi, M. S., Jayaseelan, D. L., Pritchard, J., Hadden, R. D. M., Manji, H., Willison, H. J., Rinaldi, S., Carr, A. S., & Lunn, M. P.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-12-14
- Volume
- 144
- Issue
- 2
- Pages
- 682-693
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W3112455590
- Cited by
- 333
- References
- 33
- FWCI
- 23.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.